+All Educate

All medicines containing codeine were reclassified as prescription medicines on 5 November 2020. Clinical advisory pharmacists Linda Bryant and John Dunlop discuss reasons for this decision and provide tips for pharmacists to help patients with the transition

This article, by consultant neurologist John Mottershead, looks briefly at the aetiology, pathophysiology and diagnosis of multiple sclerosis before exploring the approaches for treating relapses and symptoms of MS. It also discusses current disease-modifying treatments in detail

This article, written by specialist dermatologist Louise Reiche, aims to help pharmacists better understand the pathogenesis of psoriasis, feel confident about the available treatment options and provide the best advice to patients